updating its technological systems to ensure that it can cope with possibility of a significant surge in transaction volume. Nonetheless, commercial banks are likely to be exposed to technological failure
% 51.41 63.64% 4. Livestock 11.47 3.62% 9.27 2.50% (2.20) (19.18%) Total Sales revenues 316.83 100.00% 371.33 100.00% 54.50 17.20% Such growth was driven by a surge in revenues from sales of companion
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
administrative expenses for the three months period ended 31 March 2018 and 2019 at THB 34.11 million and THB 40.14 million respectively. This equals to a surge of 17.68 % in administrative expenses year on year
& expenses (net of tax) from the comparing quarters, the normalized net profit would be approximately THB 72.8 million in 2Q19 comparing to THB 52.4 million in 2Q18 or a surge of 39% . Statement of Financial
. Tambon Tarsit, Amohoe Pluag-daeng, Rayong As of June 30, 2018 the Company and its subsidiary had a significant surge in trade and other receivables when compared to last year which was mainly from an
) “securities lending” “SET” “share warrants” “single entity limit” “SIP” Specific Investment Products P a g e 8 | ( ) KTFFE86 86 Krung Thai Fixed Income FIF Enhanced86 Not for Retail Investors “sovereign rating
LIMITED (BCH) Mr. PIPHOB VEERAPHONG Reporter Common Share 29/09/2021 100,000 21.40 Sale Link BANGKOK CHAIN HOSPITAL PUBLIC COMPANY LIMITED (BCH) Mr. SURAPANT TAWEEWIKAYAKARN Reporter Single Stock Future
PUBLIC COMPANY LIMITED (IVL) Mr. WILLIAM ELLWOOD HEINECKE Reporter Single Stock Future (TFEX) 29/09/2020 100 21.20 Purchase Link INDORAMA VENTURES PUBLIC COMPANY LIMITED (IVL) Mr. WILLIAM ELLWOOD HEINECKE